Literature DB >> 22436975

Repeated courses of antenatal corticosteroids have adverse effects on aspects of brain development in naturally delivered baboon infants.

Amy Shields1, Merran Thomson, Vicki Winter, Jacqueline Coalson, Sandra Rees.   

Abstract

INTRODUCTION: Repeated courses of antenatal steroids in women at risk of preterm delivery have beneficial effects on lung maturation, but concern exists about the effects on brain development. We aimed to determine whether repeated courses of corticosteroids increased the risk of neuropathology as compared with single courses or no treatment.
METHODS: Single-course animals received a 6-mg dose of steroids at 123 and 124 d of gestation (dg; term, 185 dg; n = 6). Repeated-course animals received additional doses at 137 and 138 dg (n = 7). Controls received no steroids (n = 5). Baboons delivered naturally at term and necropsy was performed. Brains were assessed histologically for parameters of development and neuropathology.
RESULTS: Body weights did not differ between the groups (P > 0.05); neither did brain/body weight ratio. Density of glial fibrillary acidic protein (GFAP)-immunoreactive (IR) astrocytes in white matter (WM) was increased in the single- (P < 0.05) and repeated-course (P < 0.01) groups as compared with controls. Density of myelin basic protein (MBP)-IR oligodendrocytes was reduced in the repeated-course animals as compared with both the control and single-course groups (P < 0.05); oligodendrocyte transcription factor 2 (Olig2)-IR showed no difference between groups. DISCUSSION: Repeated courses of antenatal corticosteroids have effects on myelination in the developing nonhuman primate brain, which should be taken into account when determining a dosing regimen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22436975      PMCID: PMC3582393          DOI: 10.1038/pr.2012.18

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  36 in total

Review 1.  Antenatal corticosteroids: the good, the bad and the unknown.

Authors:  John P Newnham; Timothy J M Moss; Ilias Nitsos; Deborah M Sloboda
Journal:  Curr Opin Obstet Gynecol       Date:  2002-12       Impact factor: 1.927

2.  Determinants of conduction velocity in myelinated nerve fibers.

Authors:  S G Waxman
Journal:  Muscle Nerve       Date:  1980 Mar-Apr       Impact factor: 3.217

Review 3.  Antenatal steroids and the developing brain.

Authors:  A Whitelaw; M Thoresen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

Review 4.  Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis.

Authors:  Outi M Peltoniemi; M Anneli Kari; Mikko Hallman
Journal:  Acta Obstet Gynecol Scand       Date:  2011-05-20       Impact factor: 3.636

5.  Antenatal corticosteroids policies in 14 European countries: factors associated with multiple courses. The EURAIL survey.

Authors:  J P Empana; M M Anceschi; I Szabo; E V Cosmi; G Breart; P Truffert
Journal:  Acta Paediatr       Date:  2004-10       Impact factor: 2.299

6.  Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity.

Authors:  Arsenio Spinillo; Franco Viazzo; Rossella Colleoni; Alberto Chiara; Rosa Maria Cerbo; Elisa Fazzi
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

Review 7.  Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review.

Authors:  Kristin J McLaughlin; Caroline A Crowther; Natalie Walker; Jane E Harding
Journal:  Aust N Z J Obstet Gynaecol       Date:  2003-04       Impact factor: 2.100

8.  Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain.

Authors:  Iwa Antonow-Schlorke; Matthias Schwab; Cun Li; Peter W Nathanielsz
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

9.  Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior.

Authors:  Noel P French; Ronald Hagan; Sharon F Evans; Annie Mullan; John P Newnham
Journal:  Am J Obstet Gynecol       Date:  2004-03       Impact factor: 8.661

10.  A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis.

Authors:  Arjan Scheepens; Marjo van de Waarenburg; Daniël van den Hove; Carlos E Blanco
Journal:  J Physiol       Date:  2003-08-08       Impact factor: 5.182

View more
  5 in total

Review 1.  Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.

Authors:  Vincenzo Salpietro; Agata Polizzi; Gabriella Di Rosa; Anna Claudia Romeo; Valeria Dipasquale; Paolo Morabito; Valeria Chirico; Teresa Arrigo; Martino Ruggieri
Journal:  Int J Endocrinol       Date:  2014-09-03       Impact factor: 3.257

2.  Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor.

Authors:  Sean C Blackwell; Erin M Sullivan; Allison A Petrilla; Xian Shen; Kathleen A Troeger; James D Byrne
Journal:  Clinicoecon Outcomes Res       Date:  2017-10-03

3.  Does Antenatal Betamethasone Alter White Matter Brain Development in Growth Restricted Fetal Sheep?

Authors:  Amy E Sutherland; Tamara Yawno; Margie Castillo-Melendez; Beth J Allison; Atul Malhotra; Graeme R Polglase; Leo J Cooper; Graham Jenkin; Suzanne L Miller
Journal:  Front Cell Neurosci       Date:  2020-04-30       Impact factor: 5.505

4.  Effects of Long-Term Endogenous Corticosteroid Exposure on Brain Volume and Glial Cells in the AdKO Mouse.

Authors:  Jorge Miguel Amaya; Ernst Suidgeest; Isabelle Sahut-Barnola; Typhanie Dumontet; Nathanaëlle Montanier; Guilhem Pagès; Cécile Keller; Louise van der Weerd; Alberto M Pereira; Antoine Martinez; Onno C Meijer
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

5.  How do corticosteroids influence myelin genesis in the central nervous system?

Authors:  Divya M Chari
Journal:  Neural Regen Res       Date:  2014-05-01       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.